Springe direkt zu Inhalt

519. Nanocrystals for Improved Drug Delivery of Dexamethasone in Skin Investigated by EPR Spectroscopy

S. B. Lohan, S. Saeidpour, M. Colombo, S. Staufenbiel, M. Unbehauen, A. Wolde-Kidan, R. R.Netz, R. Bodmeier, R. Haag, C. Teutloff, R. Bittl, M. C. Meinke – 2020

Nanocrystals represent an improvement over the traditional nanocarriers for dermal application, providing the advantages of 100% drug loading, a large surface area, increased adhesion, and the potential for hair follicle targeting. To investigate their advantage for drug delivery, compared to a base cream formulation, dexamethasone (Dx), a synthetic glucocorticoid frequently used for the treatment of inflammatory skin diseases, was covalently linked with the paramagnetic probe 3-(carboxy)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy (PCA) to DxPCA. To investigate the penetration efficiency between these two vehicles, electron paramagnetic resonance (EPR) spectroscopy was used, which allows the quantification of a spin-labeled drug in different skin layers and the monitoring of the drug release. The penetration behavior in excised healthy and barrier-disrupted porcine skin was monitored by EPR, and subsequently analyzed using a numerical diffusion model. As a result, diffusion constants and free energy values in the different layers of the skin were identified for both formulations. Dx-nanocrystals showed a significantly increased drug amount that penetrated into viable epidermis and dermis of intact (factor 3) and barrier-disrupted skin (factor 2.1) compared to the base cream formulation. Furthermore, the observed fast delivery of the spin-labeled drug into the skin (80% DxPCA within 30 min) and a successive release from the aggregate unit into the viable tissue makes these nanocrystals very attractive for clinical applications.

Title
519. Nanocrystals for Improved Drug Delivery of Dexamethasone in Skin Investigated by EPR Spectroscopy
Author
S. B. Lohan, S. Saeidpour, M. Colombo, S. Staufenbiel, M. Unbehauen, A. Wolde-Kidan, R. R.Netz, R. Bodmeier, R. Haag, C. Teutloff, R. Bittl, M. C. Meinke
Date
2020
Identifier
DOI: 10.3390/pharmaceutics12050400
Source(s)
Citation
Pharmaceutics, 2020, 12(5):400
Type
Text